Paper30103348
Centronuclear myopathies under attack: A plethora of therapeutic targets.
Tasfaout H and 2 others. J Neuromuscul Dis, 2018. Cited by 37 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Centronuclear myopathies under attack: A plethora of therapeutic targets. Papers, record 30103348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30103348
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myopathies, Structural, Congenital | Major topic |
| Animals | |
| Humans |
Source PubMed
References165
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17537630 | Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy. | Neuromuscul Disord | 2007 | https://conductscience.org/library/papers/17537630 | PubMed |
| 2 | 20227276 | Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. | Neuromuscul Disord | 2010 | https://conductscience.org/library/papers/20227276 | PubMed |
| 3 | 24726641 | Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice. | Am J Pathol | 2014 | https://conductscience.org/library/papers/24726641 | PubMed |
| 4 | 18817572 | Centronuclear (myotubular) myopathy. | Orphanet J Rare Dis | 2008 | https://conductscience.org/library/papers/18817572 | PubMed |
| 5 | 20379207 | The emerging mechanisms of isoform-specific PI3K signalling. | Nat Rev Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20379207 | PubMed |
| 6 | 28370029 | Long-term effects of systemic gene therapy in a canine model of myotubular myopathy. | Muscle Nerve | 2017 | https://conductscience.org/library/papers/28370029 | PubMed |
| 7 | 11846405 | Functional redundancy in the myotubularin family. | Biochem Biophys Res Commun | 2002 | https://conductscience.org/library/papers/11846405 | PubMed |
| 8 | 21737882 | Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21737882 | PubMed |
| 9 | 29246969 | Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy. | EMBO Mol Med | 2018 | https://conductscience.org/library/papers/29246969 | PubMed |
| 10 | 22818856 | Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores. | Am J Hum Genet | 2012 | https://conductscience.org/library/papers/22818856 | PubMed |
| 11 | 18434328 | AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. | Hum Mol Genet | 2008 | https://conductscience.org/library/papers/18434328 | PubMed |
| 12 | 11504939 | Characterization of an adapter subunit to a phosphatidylinositol (3)P 3-phosphatase: identification of a myotubularin-related protein lacking catalytic activity. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11504939 | PubMed |
| 13 | 22717743 | Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. | Gene Ther | 2013 | https://conductscience.org/library/papers/22717743 | PubMed |
| 14 | 9438853 | Role of dynamin in the formation of transport vesicles from the trans-Golgi network. | Science | 1998 | https://conductscience.org/library/papers/9438853 | PubMed |
| 15 | 9398675 | Ubiquitously expressed dynamin-II has a higher intrinsic GTPase activity and a greater propensity for self-assembly than neuronal dynamin-I. | Mol Biol Cell | 1997 | https://conductscience.org/library/papers/9398675 | PubMed |
| 16 | 29408998 | Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice. | J Neuropathol Exp Neurol | 2018 | https://conductscience.org/library/papers/29408998 | PubMed |
| 17 | 20723755 | Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. | Cell | 2010 | https://conductscience.org/library/papers/20723755 | PubMed |
| 18 | 22068590 | Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. | Hum Mol Genet | 2012 | https://conductscience.org/library/papers/22068590 | PubMed |
| 19 | 23975875 | Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. | Neurology | 2013 | https://conductscience.org/library/papers/23975875 | PubMed |
| 20 | 19498037 | Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing. | Hum Mol Genet | 2009 | https://conductscience.org/library/papers/19498037 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42717511 | X-linked myotubular myopathy, liver disease, and gene therapy. | J Neuromuscul Dis | 2026 | https://conductscience.org/library/papers/42717511 | PubMed |
| 42201138 | Beyond Membrane Remodeling: Organelle Crosstalk and Convergent Pathology in Centronuclear Myopathy. | Muscles | 2026 | https://conductscience.org/library/papers/42201138 | PubMed |
| 41321131 | Dynamic expression and differential requirement of the myocyte fusogen Myomixer during distinct myogenic episodes in the zebrafish. | Biol Open | 2025 | https://conductscience.org/library/papers/41321131 | PubMed |
| 38805272 | MTM1-mediated production of phosphatidylinositol 5-phosphate fuels the formation of podosome-like protrusions regulating myoblast fusion. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38805272 | PubMed |
| 38364889 | Phosphoinositide switches in cell physiology - From molecular mechanisms to disease. | J Biol Chem | 2024 | https://conductscience.org/library/papers/38364889 | PubMed |
| 37490339 | Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37490339 | PubMed |
| 36943412 | Inactivating the lipid kinase activity of PI3KC2β is sufficient to rescue myotubular myopathy in mice. | JCI Insight | 2023 | https://conductscience.org/library/papers/36943412 | PubMed |
| 36369230 | Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy. | Nat Commun | 2022 | https://conductscience.org/library/papers/36369230 | PubMed |
| 36161941 | Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/36161941 | PubMed |
| 35293586 | Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy. | Dis Model Mech | 2022 | https://conductscience.org/library/papers/35293586 | PubMed |
| 34768808 | Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34768808 | PubMed |
| 34685492 | Muscle Regeneration and RNA: New Perspectives for Ancient Molecules. | Cells | 2021 | https://conductscience.org/library/papers/34685492 | PubMed |
| 34371181 | Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes. | Mol Ther | 2022 | https://conductscience.org/library/papers/34371181 | PubMed |
| 34297919 | Genetic diseases in the omics era. | Mol Ther | 2021 | https://conductscience.org/library/papers/34297919 | PubMed |
| 34257452 | Molecular and cellular basis of genetically inherited skeletal muscle disorders. | Nat Rev Mol Cell Biol | 2021 | https://conductscience.org/library/papers/34257452 | PubMed |
| 34072258 | Striated Preferentially Expressed Protein Kinase (SPEG) in Muscle Development, Function, and Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34072258 | PubMed |
| 33940157 | Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. | Mol Ther | 2021 | https://conductscience.org/library/papers/33940157 | PubMed |
| 33926407 | Clinical and genetic analysis of a case with centronuclear myopathy caused by SPEG gene mutation: a case report and literature review. | BMC Pediatr | 2021 | https://conductscience.org/library/papers/33926407 | PubMed |
| 33407688 | Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy. | Orphanet J Rare Dis | 2021 | https://conductscience.org/library/papers/33407688 | PubMed |
| 33355670 | SPEG binds with desmin and its deficiency causes defects in triad and focal adhesion proteins. | Hum Mol Genet | 2021 | https://conductscience.org/library/papers/33355670 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30103348
GET https://conductscience.org/api/papers/v1/30103348/references?page=2